Study #ALLIANCEAFT - 25
COMET trial for low risk DCIS
MD Anderson Study Status
This study looks at the risks and benefits of active monitoring (AM) compared to surgery in the setting of a pragmatic prospective randomized trial for low risk DCIS. Our overarching hypothesis is that management of low-risk Ductal Carcinoma in Situ (DCIS) using an AM approach does not yield inferior cancer or quality of life outcomes compared to surgery.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
DCIS, Ductal Carcinoma in Situ
Breast Surgical Oncology
For general questions about clinical trials:
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.